Your fact-checks will appear here
A rare blood clotting disorder associated with adenoviral-vector vaccines, characterized by thrombocytopenia and the presence of anti-platelet-factor-4 antibodies.
New research continues to appear on : large population studies, systematic reviews, case series and comparative cohort work through 2024–2025 refine the signal that rare thrombotic events do occur—mos...
Pharmacovigilance databases and post‑marketing reviews have repeatedly flagged a small set of immune‑mediated disorders temporally linked to the Janssen Ad26.COV2.S vaccine—most prominently vaccine‑in...